Effectiveness of cognitive-behavioral therapy on pain perception and metacognitive beliefs in patients with irritable bowel syndrome
Social Determinants of Health,
Vol. 8 (2022),
1 January 2022
,
Page 1-9
https://doi.org/10.22037/sdh.v8i1.36923
Abstract
Background: The most common, costly, and debilitating functional gastrointestinal disorder is irritable bowel syndrome (IBS). This study aimed to determine the effectiveness of cognitive-behavioral therapy on metacognitive beliefs and pain problems in patients with irritable bowel syndrome.
Methods: The study used a quasi-experimental design with pre-test, post-test and a three-month follow-up with the control group. All patients with irritable bowel syndrome at Tehran Shariatee Hospital were included in the statistical population. The sample consisted of 30 patients who were randomly assigned to experimental and control groups using the purposive sampling method. Before the intervention, the pre-test was held, after which the experimental group received cognitive-behavioral therapy in 8 sessions of 90 minutes, but the control group did not receive any intervention. Then, the post-test was administered and after three months of post-test implementation, the follow-up period was performed. The research tools included a metacognitive beliefs questionnaire and pain understanding. Data analysis was performed by SPSS.22 software and univariate variance analysis.
Results: The experimental group was 33.6 (7.8) years old, while the control group was 35.9 (8.4) years old. Both groups were homogenous in terms of gender, age and marital status. The findings showed that cognitive-behavioral therapy was effective on metacognitive beliefs (P<0.01) and pain affect (P<0.01).
Conclusion: It can be concluded that cognitive-behavioral therapy is effective in treating metacognitive beliefs and pain in patients with irritable bowel syndrome, and that it can be used to help these patients.
- Cognitive Behavioral Therapy
- Irritable Bowel Syndrome
- Metacognition
- Pain Perception
How to Cite
References
Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Annals of internal medicine. 2015 Aug 4;163(3):191-204.
Olatunji BO, Davis ML, Powers MB, Smits JA. Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderators. Journal of psychiatric research. 2013 Jan 1;47(1):33-41.
Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. Jama. 2015 Mar 3;313(9):949-58.
Chumpitazi BP, Cope JL, Hollister EB, Tsai CM, McMeans AR, Luna RA, Versalovic J, Shulman RJ. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary pharmacology & therapeutics. 2015 Aug;42(4):418-27.
Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP‐restricted diet in the management of constipation and irritable bowel syndrome. Alimentary pharmacology & therapeutics. 2015 Jun;41(12):1256-70.
Gilbert W, Rushton J. Incentive perception in livestock disease control. Journal of agricultural economics. 2018 Feb;69(1):243-61.
Frantz C, Avouac J, Distler O, Amrouche F, Godard D, Kennedy AT, Connolly K, Varga J, Matucci-Cerinic M, Allanore Y. Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey. InSeminars in arthritis and rheumatism 2016 Aug 1 (Vol. 46, No. 1, pp. 115-123). WB Saunders.
Keinki C, Seilacher E, Ebel M, Ruetters D, Kessler I, Stellamanns J, Rudolph I, Huebner J. Information needs of cancer patients and perception of impact of the disease, of self-efficacy, and locus of control. Journal of Cancer Education. 2016 Sep;31(3):610-6.
Boateng D, Wekesah F, Browne JL, Agyemang C, Agyei-Baffour P, Aikins AD, Smit HA, Grobbee DE, Klipstein-Grobusch K. Knowledge and awareness of and perception towards cardiovascular disease risk in sub-Saharan Africa: A systematic review. PloS one. 2017 Dec 12;12(12):e0189264.
Lavallée MM, Gandini D, Rouleau I, Vallet GT, Joannette M, Kergoat MJ, Busigny T, Rossion B, Joubert S. A qualitative impairment in face perception in Alzheimer’s disease: Evidence from a reduced face inversion effect. Journal of Alzheimer's Disease. 2016 Jan 1;51(4):1225-36.
Jinga M, Popp A, Balaban DV, Dima A, Jurcut C. Physicians’ attitude and perception regarding celiac disease: A questionnaire-based study. The Turkish journal of gastroenterology. 2018 Jul;29(4):419.
McEvoy PM, Mahoney AE. Intolerance of uncertainty and negative metacognitive beliefs as transdiagnostic mediators of repetitive negative thinking in a clinical sample with anxiety disorders. Journal of Anxiety Disorders. 2013 Mar 1;27(2):216-24.
Smith KE, Hudson JL. Metacognitive beliefs and processes in clinical anxiety in children. Journal of Clinical Child & Adolescent Psychology. 2013 Sep 1;42(5):590-602.
Flavell JH. Metacognition and cognitive monitoring: A new area of cognitive–developmental inquiry. American psychologist. 1979 Oct;34(10):906.
Rahimian GhA, Babaeian M, Kheiri S, Moradi MT and Rafieian-Kopaei M. Effect of Glycyrrhiza Glabra (D-reglis tablet) on pain and defecation of patients wit irritable bowel syndrome. J. Birjand Univ. Med. Sci. 2010; 17 (4): 240-248.Farsi
Van Tilburg MA, Palsson OS, Ringel Y, Whitehead WE. Is ginger effective fo the treatment of Irritable Bowel Syndrome? A double blind randomized controlled pilot trial Complement. Ther. Med. 2014; 22 (1): 17-20.
Cook SA, Salmon P, Dunn G, Holcombe C, Cornford P, Fisher P. The association of metacognitive beliefs with emotional distress after diagnosis of cancer. Health Psychology. 2015 Mar;34(3):207.
Zettle RD, Hayes SC. Rule-Governed Behavior: A Potential Theoretical Framework for Cognitive-Behavioral Therapy. InThe Act in Context 2015 Oct 16 (pp. 33-63). Routledge.
Andreae SJ, Andreae LJ, Cherrington AL, Lewis M, Johnson E, Clark D, Safford MM. Development of a community health worker delivered cognitive behavioral training intervention for individuals with diabetes and chronic pain. Family & community health. 2018 Jul;41(3):178.
Menting J, Tack CJ, Donders R, Knoop H. Potential mechanisms involved in the effect of cognitive behavioral therapy on fatigue severity in Type 1 diabetes. Journal of consulting and clinical psychology. 2018 Apr;86(4):330.
Onyechi KC, Eseadi C, Okere AU, Onuigbo LN, Umoke PC, Anyaegbunam NJ, Otu MS, Ugorji NJ. Effects of cognitive behavioral coaching on depressive symptoms in a sample of type 2 diabetic inpatients in Nigeria. Medicine. 2016 Aug;95(31).
Shirinzade dastgiri M, Goudarzi MA, Ghanizade A, Taghavi, MR Factor structure, validity and reliability of meta-cognition 30. The J Psychol. 2008; (48): 461- 445. Farsi
Khosravi M, Sadighi S, Moradi SH, Zendehdel K. Persian-McGill pain questionnaire; translation, adaptation and reliability in cancer patients: a brief report. Tehran University of Medical Sciences. 2013; 71(1): 53-8. Farsi
Wells A, Cartwright-Hatton S. A short form of the metacognitions questionnaire: properties of the MCQ-30. Behaviour research and therapy. 2004 Apr 1;42(4):385-96.
Postolica R, Iorga M, Petrariu FD, Azoicai D. Cognitive-behavioral coping, illness perception, and family adaptability in oncological patients with a family history of cancer. BioMed research international. 2017 Jan 1;2017.
Baber, K., & Rodriguez, K. A. O. (2019). Cognitive behavioral therapy for functional abdominal pain disorders. In R. D. Friedberg & J. K. Paternostro (Eds.), Handbook of cognitive behavioral therapy for pediatric medical conditions (pp. 201–217). Springer Nature Switzerland AG. https://doi.org/10.1007/978-3-030-21683-2_14
Melzack R. The short-form McGill Pain questionnaire. pain. 1987; 30(2): 191-7
Hoffart A, Johnson SU, Nordahl HM, Wells A. Mechanisms of change in metacognitive and cognitive behavioral therapy for treatment-resistant anxiety: The role of metacognitive beliefs and coping strategies. Journal of Experimental Psychopathology. 2018 Aug 1;9(3):2043808718787414.
Shou H, Yang Z, Satterthwaite TD, Cook PA, Bruce SE, Shinohara RT, Rosenberg B, Sheline YI. Cognitive behavioral therapy increases amygdala connectivity with the cognitive control network in both MDD and PTSD. NeuroImage: Clinical. 2017 Jan 1;14:464-70.
Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JA, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: A meta‐analysis of randomized placebo‐controlled trials. Depression and anxiety. 2018 Jun;35(6):502-14.
- Abstract Viewed: 165 times
- PDF Downloaded: 172 times